The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study
Crossref DOI link: https://doi.org/10.1186/1471-2288-14-66
Published Online: 2014-05-15
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pratt, Nicole L
Ilomäki, Jenni
Raymond, Chris
Roughead, Elizabeth E
License valid from 2014-05-15
Article History
Received: 8 November 2013
Accepted: 6 May 2014
First Online: 15 May 2014